Company Overview and News

 
Institutional Activity in Magellan Midstream Partners in Q1 2018

15h marketrealist
The total number of institutional holders in Magellan Midstream Partners (MMP) had fallen to 695 by the end of the first quarter compared to 713 in the previous quarter. However, the percentage of its shares held by institutional investors increased to 64.4% from 61.6%.

 
Top Losses in the Energy Sector Last Week

18h marketrealist
On May 11–18, midstream stock Spectra Energy Partners (SEP) fell the most on our list of energy stocks. During this period, the Alerian MLP ETF (AMLP) rose 3.3%—the second-lowest rise among the energy subsector ETFs discussed in Part 2.

 
MLPs Outperform In The Simplicity War

2018-05-20 seekingalpha
Midstream overall outperformed and MLPs again led the way, up another 3.1%. The MLP Index is now up 14.4% the last 8 weeks, rallying in 6 of those 8 weeks. Energy and oil prices continue to trade well, with MLPs trying to keep pace with broad energy stocks. News flow was light until Thursday's simplification party. Weaker Canadian and utility performance dragged down the broader AMEI midstream index performance.

 
Top MLPs: SUN, ETP, and BPL Yield above 12%

2018-05-18 marketrealist
Sunoco (SUN) is trading at a yield of ~12.3%. The company paid a distribution of $0.83 per unit for the first quarter. On May 11, RBC cut its target price for Sunoco from $36 to $34. On May 10, UBS cut its price target for Sunoco from $29 to $27.

 
MLPs: Buy After Distribution Cuts Or Run Away?

2018-05-17 seekingalpha
Many income investors sell on cuts to dividends and distributions. Other investors take a vulture-like approach and buy. Who is right?

 
50 Energy Sector Top Yield And 50 Top Wall St. Target Dividend Stocks For May

2018-05-17 seekingalpha
Energy firms with at least 0.71 broker target upside and 2% dividend yield showed midstream firms high on lists led by Blueknight Energy for upside and Sandridge for yield.

 
Buckeye Partners, Focus On Growth And Cash Flows For This 13% Yielder

2018-05-10 seekingalpha
BPL reported that dividend coverage will be weak for the 2nd and 3rd quarters using distributable cash flow ratios (DCF).

 
Plains All American (PAA) Beats on Q1 Earnings & Revenues

2018-05-09 zacks
Plains All American Pipeline, L.P. (PAA - Free Report) reported first-quarter 2018 adjusted earnings of 36 cents per unit, beating the Zacks Consensus Estimate of 31 cents by 16.13%. Reported earnings increased 33.3% from 27 cents in the year-ago quarter. In the quarter under review, the partnership reported a GAAP earnings of 33 cents per unit excluding onetime items. Total Revenues In the first-quarter, the partnership reported total revenues of $8,398 million, which beat the Zacks Consensus Estimate of $7,435 million by 12.

 
30 Dividend Contenders Show 4.68-12.91% Yields Backed By 10-24 Years Of Increases

2018-05-09 seekingalpha
Broker target-estimated May Dividend Contender top-ten net-gains ranged 20%-43.7%, from BIP, QCOM, TCP, EPD, ENB, ETE, SEP, PM, TLP, and were topped by ETP as selected 4/30/18 and measured 5/7/18.

 
30 Dividend Contenders Show 4.68%-12.91% Yields Backed By 10-24 Years Of Increases

2018-05-09 seekingalpha
Broker target-estimated May Dividend Contender top-ten net-gains ranged 20%-43.7%, from BIP, QCOM, TCP, EPD, ENB, ETE, SEP, PM, TLP, and were topped by ETP as selected 4/30/18 and measured 5/7/18.

 
John And Jane - April Dividend Income Tracker - Taxable Account

2018-05-08 seekingalpha
This is the 6th month I have officially tracked dividend income, and it was slightly below expectations with a total of $619.98 of dividends received.

 
Andeavor Logistics' (ANDX) CEO Greg Goff on Q1 2018 Results - Earnings Call Transcript

2018-05-08 seekingalpha
Andeavor Logistics webcast, which includes a review of the progress we are making on our business plans, financial strategies as well as our first quarter earnings. Greg Goff, Chairman and CEO and Steven Sterin, President and CFO will be presenting during this webcast.

 
Buckeye Partners' (BPL) CEO Clark Smith on Q1 2018 Results - Earnings Call Transcript

2018-05-04 seekingalpha
Buckeye Partners L.P. (NYSE:BPL) Q1 2018 Results Earnings Conference Call May 4, 2018 11:00 AM ET

Related Articles

ANTH: Anthera Pharmaceuticals Analysis and Research Report

16h - Asif

Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...

AGEN: Agenus Inc Analysis and Research Report

16h - Asif

Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...

SQ: Square Analysis and Research Report

2018-05-21 - Asif

Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...

CUSIP: 118230101